MetLife Investment Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.64M | Sell |
27,654
-608
| -2% | -$58.4K | 0.01% | 984 |
|
|
2026
Q1 | $2.93M | Sell |
28,262
-974
| -3% | -$110K | 0.01% | 859 |
|
|
2025
Q4 | $2.95M | Sell |
29,236
-1,122
| -4% | -$122K | 0.01% | 872 |
|
|
2025
Q3 | $3.74M | Sell |
30,358
-1,043
| -3% | -$129K | 0.02% | 763 |
|
|
2025
Q2 | $3.77M | Sell |
31,401
-6,013
| -16% | -$802K | 0.02% | 696 |
|
|
2025
Q1 | $5.51M | Sell |
37,414
-822
| -2% | -$126K | 0.03% | 563 |
|
|
2024
Q4 | $6.21M | Buy |
38,236
+375
| +1% | +$61.3K | 0.03% | 445 |
|
|
2024
Q3 | $6.17M | Sell |
37,861
-1,015
| -3% | -$150K | 0.04% | 426 |
|
|
2024
Q2 | $5.31M | Buy |
38,876
+4,718
| +14% | +$655K | 0.03% | 453 |
|
|
2024
Q1 | $5.23M | Sell |
34,158
-1,028
| -3% | -$153K | 0.04% | 461 |
|
|
2023
Q4 | $5.02M | Sell |
35,186
-586
| -2% | -$78.1K | 0.04% | 450 |
|
|
2023
Q3 | $4.69M | Sell |
35,772
-755
| -2% | -$115K | 0.04% | 443 |
|
|
2023
Q2 | $5.81M | Buy |
36,527
+583
| +2% | +$94K | 0.04% | 369 |
|
|
2023
Q1 | $5.69M | Sell |
35,944
-340
| -0.9% | -$51K | 0.04% | 378 |
|
|
2022
Q4 | $5.09M | Sell |
36,284
-644
| -2% | -$91.4K | 0.04% | 425 |
|
|
2022
Q3 | $4.74M | Sell |
36,928
-412
| -1% | -$59.5K | 0.04% | 431 |
|
|
2022
Q2 | $5.26M | Sell |
37,340
-591
| -2% | -$84.4K | 0.04% | 392 |
|
|
2022
Q1 | $5.27M | Buy |
37,931
+10,786
| +40% | +$1.65M | 0.03% | 492 |
|
|
2021
Q4 | $4.73M | Sell |
27,145
-592
| -2% | -$98.7K | 0.04% | 423 |
|
|
2021
Q3 | $4.59M | Sell |
27,737
-1,098
| -4% | -$189K | 0.04% | 413 |
|
|
2021
Q2 | $5.19M | Sell |
28,835
-1,141
| -4% | -$208K | 0.05% | 363 |
|
|
2021
Q1 | $5.78M | Sell |
29,976
-636
| -2% | -$122K | 0.05% | 324 |
|
|
2020
Q4 | $6.18M | Sell |
30,612
-1,389
| -4% | -$287K | 0.06% | 295 |
|
|
2020
Q3 | $6.73M | Sell |
32,001
-718
| -2% | -$160K | 0.07% | 230 |
|
|
2020
Q2 | $7.18M | Buy |
32,719
+369
| +1% | +$73.7K | 0.08% | 207 |
|
|
2020
Q1 | $5.6M | Sell |
32,350
-990
| -3% | -$164K | 0.08% | 214 |
|
|
2019
Q4 | $5.12M | Sell |
33,340
-879
| -3% | -$131K | 0.05% | 341 |
|
|
2019
Q3 | $5.2M | Sell |
34,219
-889
| -3% | -$141K | 0.06% | 317 |
|
|
2019
Q2 | $5.38M | Sell |
35,108
-1,324
| -4% | -$202K | 0.06% | 320 |
|
|
2019
Q1 | $5.85M | Sell |
36,432
-75
| -0.2% | -$11.6K | 0.06% | 281 |
|
|
2018
Q4 | $5.63M | Sell |
36,507
-754
| -2% | -$117K | 0.07% | 260 |
|
|
2018
Q3 | $5.6M | Sell |
37,261
-863
| -2% | -$123K | 0.06% | 322 |
|
|
2018
Q2 | $5.16M | Sell |
38,124
-819
| -2% | -$101K | 0.06% | 294 |
|
|
2018
Q1 | $5.18M | Sell |
38,943
-952
| -2% | -$128K | 0.06% | 307 |
|
|
2017
Q4 | $5.93M | Buy |
+39,895
| New | +$5.43M | 0.07% | 278 |
|
Other funds holding CLX
MetLife Investment Management's CLX Position: Q2 2026 in Review
MetLife Investment Management reduced its Clorox (CLX) stake by 2.2% in Q2 2026, selling an estimated $58.4K and leaving 27,654 shares worth $2.64M. The position accounts for 0.01% of the portfolio, ranked #984.
MetLife Investment Management first reported a position in CLX in Q4 2017 and has held it in 35 quarters since. The position peaked at $7.18M in Q2 2020. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- MetLife Investment Management held 27,654 shares of Clorox worth $2.64M as of Q2 2026.
- MetLife Investment Management sold 608 Clorox shares in Q2 2026, an estimated $58.4K.
- Clorox made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #984 holding.
- MetLife Investment Management first reported a position in Clorox in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Clorox position peaked at $7.18M in Q2 2020.
- 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.